Skip to main content

Table 4 RAD21 expression in breast cancers by intrinsic subtype

From: Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Subtype

negative

n (%)

positive

n (%)

Total

n (%)

P-value

Relative to luminal

Luminal

126 (63%)

75 (37%)

201 (100%)

-

Basal-like

32 (76%)

10 (24%)

42 (100%)

0.095

HER2

38 (78%)

11 (22%)

49 (100%)

0.050

Null

23 (82%)

5 (18%)

28 (100%)

0.043

Total

239 (70%)

104 (30%)

320 (100%)

Â